These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24486417)

  • 1. Design, synthesis, pharmacological evaluation and computational studies of 1-(biphenyl-4-yl)-2-[4-(substituted phenyl)-piperazin-1-yl]ethanones as potential antipsychotics.
    Bhosale SH; Kanhed AM; Dash RC; Suryawanshi MR; Mahadik KR
    Eur J Med Chem; 2014 Mar; 74():358-65. PubMed ID: 24486417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, computational studies and preliminary pharmacological evaluation of 2-[4-(aryl substituted) piperazin-1-yl] N, N-diphenylacetamides as potential antipsychotics.
    Kumar S; Wahi AK; Singh R
    Eur J Med Chem; 2011 Sep; 46(9):4753-9. PubMed ID: 21824691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, pharmacological evaluation and descriptor based similarities study of N,N-diphenyl-2-[4-(substituted phenyl)piperazin-1-yl]acetamides as potential antipsychotics.
    Dash RC; Bhosale SH; Shelke SM; Suryawanshi MR; Mahadik KR
    Med Chem; 2012 Nov; 8(6):1069-75. PubMed ID: 22779792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of N-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-2-aryl-2-yl-acetamides and 1-{[2-(4-phenyl-piperazin-1-yl)-ethyl]-phenyl}-3-aryl-2-yl-ureas with dopamine D2 and 5-hydroxytryptamine 5HT(1A) receptors.
    Sukalovic V; Ignjatovic D; Tovilovic G; Andric D; Shakib K; Kostic-Rajacic S; Soskic V
    Bioorg Med Chem Lett; 2012 Jun; 22(12):3967-72. PubMed ID: 22607670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and preliminary screening of novel N-{2-[4-(substituted)piperazin-1-yl]-2-oxoethyl}acetamides as potential atypical antipsychotic agents.
    Chandra Sekhar KV; Rao VS; Krishna MM
    J Enzyme Inhib Med Chem; 2009 Jun; 24(3):871-5. PubMed ID: 18825551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and SAR of (piperazin-1-yl-phenyl)-arylsulfonamides: a novel series of atypical antipsychotic agents.
    Park CM; Kim SY; Park WK; Choi JH; Seong CM
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5221-4. PubMed ID: 20655748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT₁A/5-HT₂A/5-HT₇ and dopamine D₂/D₃ receptors.
    Zajdel P; Marciniec K; Maślankiewicz A; Grychowska K; Satała G; Duszyńska B; Lenda T; Siwek A; Nowak G; Partyka A; Wróbel D; Jastrzębska-Więsek M; Bojarski AJ; Wesołowska A; Pawłowski M
    Eur J Med Chem; 2013 Feb; 60():42-50. PubMed ID: 23279866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and preliminary pharmacological evaluation of N-2-(4-(4-(2-substitutedthiazol-4-yl) piperazin-1-yl)-2-oxoethyl)acetamides as novel atypical antipsychotic agents.
    Sekhar KV; Rao VS; Devambatla RKV; Kumar MM
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6054-7. PubMed ID: 18948000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological characterization of novel hybrid 7-[[2-(4-phenyl-piperazin-1-yl)-ethyl]-propyl-amino]-5,6,7,8-tetrahydro-naphthalen-2-ol and their heterocyclic bioisosteric analogues for dopamine D2 and D3 receptors.
    Dutta AK; Venkataraman SK; Fei XS; Kolhatkar R; Zhang S; Reith ME
    Bioorg Med Chem; 2004 Aug; 12(16):4361-73. PubMed ID: 15265488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, Biological, and Computational Evaluation of Substituted 1-(2-Methoxyphenyl)-4-(1-phenethylpiperidin-4-yl)piperazines and 1-(2-Methoxyphenyl)-4-[(1-phenethylpiperidin-4-yl)methyl]piperazines as Dopaminergic Ligands.
    Penjišević JZ; Šukalović VV; Andrić DB; Roglić GM; Šoškić V; Kostić-Rajačić SV
    Arch Pharm (Weinheim); 2016 Aug; 349(8):614-26. PubMed ID: 27335270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (S)-(-)-4-[4-[2-(isochroman-1-yl)ethyl]-piperazin-1-yl] benzenesulfonamide, a selective dopamine D4 antagonist.
    TenBrink RE; Bergh CL; Duncan JN; Harris DW; Huff RM; Lahti RA; Lawson CF; Lutzke BS; Martin IJ; Rees SA; Schlachter SK; Sih JC; Smith MW
    J Med Chem; 1996 Jun; 39(13):2435-7. PubMed ID: 8691438
    [No Abstract]   [Full Text] [Related]  

  • 12. Quinoline- and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor-5-HT1A/5-HT2A/5-HT7 and D2/D3/D4-agents: the synthesis and pharmacological evaluation.
    Zajdel P; Marciniec K; Maślankiewicz A; Satała G; Duszyńska B; Bojarski AJ; Partyka A; Jastrzębska-Więsek M; Wróbel D; Wesołowska A; Pawłowski M
    Bioorg Med Chem; 2012 Feb; 20(4):1545-56. PubMed ID: 22277589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.
    Grundt P; Carlson EE; Cao J; Bennett CJ; McElveen E; Taylor M; Luedtke RR; Newman AH
    J Med Chem; 2005 Feb; 48(3):839-48. PubMed ID: 15689168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and pharmacological evaluation of new N-phenylpiperazine derivatives designed as homologues of the antipsychotic lead compound LASSBio-579.
    Pompeu TE; Alves FR; Figueiredo CD; Antonio CB; Herzfeldt V; Moura BC; Rates SM; Barreiro EJ; Fraga CA; Noël F
    Eur J Med Chem; 2013 Aug; 66():122-34. PubMed ID: 23792350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, docking and pharmacological evaluation of novel indole based potential atypical antipsychotics.
    Bali A; Sen U; Peshin T
    Eur J Med Chem; 2014 Mar; 74():477-90. PubMed ID: 24495776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antimicrobial evaluation of new chalcones containing piperazine or 2,5-dichlorothiophene moiety.
    Tomar V; Bhattacharjee G; Kamaluddin ; Kumar A
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5321-4. PubMed ID: 17719779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-substituted-1,2-benzisoxazoles: novel antipsychotic agents.
    Davis L; Effland RC; Klein JT; Dunn RW; Geyer HM; Petko WW
    Drug Des Discov; 1992 Feb; 8(3):225-40. PubMed ID: 1356026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-(omega-(4-(2-methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as dopamine D2 and D3 receptor ligands.
    Hackling A; Ghosh R; Perachon S; Mann A; Höltje HD; Wermuth CG; Schwartz JC; Sippl W; Sokoloff P; Stark H
    J Med Chem; 2003 Aug; 46(18):3883-99. PubMed ID: 12930150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New (sulfonyloxy)piperazinyldibenzazepines as potential atypical antipsychotics: chemistry and pharmacological evaluation.
    Liao Y; Venhuis BJ; Rodenhuis N; Timmerman W; Wikström H; Meier E; Bartoszyk GD; Böttcher H; Seyfried CA; Sundell S
    J Med Chem; 1999 Jun; 42(12):2235-44. PubMed ID: 10377229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological evaluation of selected arylpiperazines with atypical antipsychotic potential.
    Tomić M; Kundaković M; Butorović B; Janać B; Andrić D; Roglić G; Ignjatović D; Kostić-Rajacić S
    Bioorg Med Chem Lett; 2004 Aug; 14(16):4263-6. PubMed ID: 15261283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.